In 2014 Spectrum Pharmaceuticals Chairman and CEO Dr. Rajesh Shrotriya’s, 71, became one of the highest paid corporate executive in Southern Nevada. 

Dr. Shrotriya’s total 2014 annual compensation reached over $4.8 million which was 52% less than his 2012 compensation.  In 2012, Dr. Shrotriya’s annual compensation was over $10 million.

The 2014 total compensation includes a base salary of $900,000, annual bonus of $900,000, Stock awards $723,000, option awards $2 million and $294,000 in other compensation.  Stock and option awards reflect the aggregate grant date fair value of the respective awards.  Other compensation of $294,000 includes automobile allowance, annual 401k matching contributions, health care premium and life insurance policies.

Dr. Shrotriya also have an outstanding option awards by Spectrum Pharmaceuticals.  As of April 30^th 2015, Dr. Shrotriya has the beneficial ownership of over eight million in Spectrum’s common stock.  Additionally, the employment contract stipulates an estimated compensation of over $11 million in case of termination following a change of control of the company.